Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
暂无分享，去创建一个
E. Cerami | D. D. Del Valle | S. Kim-Schulze | Hui Xie | Manishkumar Patel | K. Tuballes | V. Barcessat | D. Duose | K. Argueta | K. Nie | O. Jegede | Edgar Gonzalez-Kozlova | Jennifer Altreuter | G. Kelly | Radim Moravec | Joyce Yu | I. Wistuba | S. Ansell | Catherine S Diefenbach | Hsin-Hui Huang | Jocelyn Harris | Brad S. Kahl | James Lindsay | Sacha Gnjatic